FindTrial
Sign In

Study for predicting hypoxemia in COVID 19 patients on the basis of HRCT thorax findings with correlating the CT findings with SpO2 levels.

â??HRCT Thorax - Is it an early predictor of hypoxemia in COVID 19 patients?â??

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027500
Enrollment
1000
Registered
2020-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

kalinga Institute of medical scineces
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All COVID positive patients with positive HRCT thorax features with simultaneous SpO2 monitoring .

Exclusion criteria

Exclusion criteria: Patients who have not undertaken HRCT thorax and SpO2 monitoring. Patients with normal HRCT thorax .

Design outcomes

Primary

MeasureTime frame
Assessing the potential for prediction of hypoxemia on HRCT thorax and Early prediction of hypoxemia if feasible, would guide physicians for prompt and early management of COVID 19 patients with low blood oxygen levels. Timepoint: 4 weeks—

Secondary

MeasureTime frame
To Correlate the HRCT Thorax findings ( CT severity Index) with SpO2. Timepoint: 4 week—

Countries

India

Contacts

Public ContactDr Kamal Kumar Sen

kalinga institute of medical sciences

drajay2610@gmail.com7453866819

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026